SlideShare una empresa de Scribd logo
1 de 10
URS-USER REQUIREMENT SPECIFICATIONS
Presented by
Girija G S
M PHARM 1ST SEM
DEPARTMENT OF
PHARMACEUTICS
MALLIGE COLLEGE OF
PHARMACY
1
2
USER REQUIREMENT SPECIFICATIONS-URS
→ Requirements regarding equipment is given by users called as
URS.
It includes,
 Size of equipment
 Speed of equipment
 Effectiveness of equipment
 Availability of spares, change parts
 Low dust and sound facilities
 Auto control systems
 Lesser breakdowns
 Overall good construction
3
 The requirement and specifications for the utility of equipment
should be defined by the user and documented in the URS.
 The URS should be used when selection of the required utility
or equipment from an approved supplier and to verify suitability
throughout the subsequent stages of qualification.
 They must be comprehensive. Each and every requirement relating to product safety,
identity, strength, purity, and quality must be identified.
 The URS can contain a large number of requirements and should therefore be
structured in a way that will permit easy access to information.
 The requirement specification must be formally reviewed and approved by the
pharmaceutical manufacturer.
4
The following guidelines should be followed during the production of
the URS:
 Each requirement statement to be uniquely referenced, and no
longer than 250words.
 Requirement statements should not be duplicated nor
contradicted.
 The URS should express requirements and not design solutions.
 Each requirement should be testable.
5
 The URS must be understood by both user and supplier; ambiguity
avoided.
 The use of diagrams is often useful
 Wherever possible, the URS should distinguish between
mandatory/regulatory requirements and desirable features.
6
U.R.S. for facilities is a statement spelling out, what the user wants in terms
of the facilities, he wants to create for the manufacturing of the
pharmaceutical formulations. It can expressed in the following manner.
The facility will be used for the manufacture of the following formulation and
volumes, namely:
1) Tablets-Coated 10L/Shift
2) Tablets-Uncoated 20L/Shift
3) Hard gelatin capsules 5L/Shift
4) Small volume parenterals 50K Amp/Shift
5) Large volume parenterals 20Kbottles of 500 ml/Shift
7
URS provides the following key benefits for the validation program:
1. Clarifies technical, quality, and documentation requirements to the
vendor(s).
2. Enables the pharmaceutical manufacturer to assess the technical,
regulatory, and commercial compliance (or otherwise) of submitted
bids against a formal specification.
3. Ensures the basis of a structured approach to the presentation of
information.
4. Provides a basis for testing and test acceptance criteria.
5. Provide a baseline for validation and verification..
8
Model Question
1) Write a note on
USR?
9
References
Pharmaceutical Process Validation, Second Edition, Revised and
Expanded, edited by Ira R. Berry, Robert a. Nash.
Validation in pharmaceutical industry; Equipment validation; A brief
review, Diksha Jindal, et al; Adesh University Journal of Medical
Sciences & Research. www.aujmsr.com
10

Más contenido relacionado

Similar a Modern pharmaceutics

Medical Device Development Firm Glossary of terms and abbreviations.pdf
Medical Device Development Firm Glossary of terms and abbreviations.pdfMedical Device Development Firm Glossary of terms and abbreviations.pdf
Medical Device Development Firm Glossary of terms and abbreviations.pdf
Alexander Sprauve
 
b.Types of validation.gayathri - gayathri murali.pptx
b.Types of validation.gayathri - gayathri murali.pptxb.Types of validation.gayathri - gayathri murali.pptx
b.Types of validation.gayathri - gayathri murali.pptx
Aarthi358332
 
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
ulmedical
 
Abbott overview medical device human factors standards
Abbott overview medical device human factors standardsAbbott overview medical device human factors standards
Abbott overview medical device human factors standards
Jones Wu
 

Similar a Modern pharmaceutics (20)

Concept of URS,DQ,IQ,OQ,PQ
Concept of URS,DQ,IQ,OQ,PQConcept of URS,DQ,IQ,OQ,PQ
Concept of URS,DQ,IQ,OQ,PQ
 
Developing Product Requirements For Medical Devices
Developing Product Requirements For Medical DevicesDeveloping Product Requirements For Medical Devices
Developing Product Requirements For Medical Devices
 
Regulatory affairs cmc , post approval regulatory affairs
Regulatory affairs   cmc , post approval regulatory affairsRegulatory affairs   cmc , post approval regulatory affairs
Regulatory affairs cmc , post approval regulatory affairs
 
Vaidation ppt.pptx
Vaidation ppt.pptxVaidation ppt.pptx
Vaidation ppt.pptx
 
Medical Device Development Firm Glossary of terms and abbreviations.pdf
Medical Device Development Firm Glossary of terms and abbreviations.pdfMedical Device Development Firm Glossary of terms and abbreviations.pdf
Medical Device Development Firm Glossary of terms and abbreviations.pdf
 
CONCEPT OF URS, DQ, IQ, OQ, PQ
CONCEPT OF URS, DQ, IQ, OQ, PQCONCEPT OF URS, DQ, IQ, OQ, PQ
CONCEPT OF URS, DQ, IQ, OQ, PQ
 
How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...
How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...
How to get your COVID-19 Related Medical Device to Market Under FDA Emergency...
 
Modification after Initial Review and Transparency and Real-World Performance...
Modification after Initial Review and Transparency and Real-World Performance...Modification after Initial Review and Transparency and Real-World Performance...
Modification after Initial Review and Transparency and Real-World Performance...
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510k
 
b.Types of validation.gayathri - gayathri murali.pptx
b.Types of validation.gayathri - gayathri murali.pptxb.Types of validation.gayathri - gayathri murali.pptx
b.Types of validation.gayathri - gayathri murali.pptx
 
Supac
SupacSupac
Supac
 
Webinar on Device Registries as PMCF tools
Webinar on Device Registries as PMCF toolsWebinar on Device Registries as PMCF tools
Webinar on Device Registries as PMCF tools
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
 
GENERIC DRUG PRODUCT DEVELOPMENT.pptx
GENERIC DRUG PRODUCT DEVELOPMENT.pptxGENERIC DRUG PRODUCT DEVELOPMENT.pptx
GENERIC DRUG PRODUCT DEVELOPMENT.pptx
 
Presentation: Conformity Assessment Evidence
Presentation: Conformity Assessment EvidencePresentation: Conformity Assessment Evidence
Presentation: Conformity Assessment Evidence
 
CVH252009 Series
CVH252009 SeriesCVH252009 Series
CVH252009 Series
 
Abbott overview medical device human factors standards
Abbott overview medical device human factors standardsAbbott overview medical device human factors standards
Abbott overview medical device human factors standards
 
Quality Function Deployment (QFD) for Design Controls
Quality Function Deployment (QFD) for Design ControlsQuality Function Deployment (QFD) for Design Controls
Quality Function Deployment (QFD) for Design Controls
 
Pilot plant scale up techniques
Pilot plant scale up techniquesPilot plant scale up techniques
Pilot plant scale up techniques
 

Más de GirijaSoori (7)

Medical ethics biostatistics and research
Medical ethics biostatistics and researchMedical ethics biostatistics and research
Medical ethics biostatistics and research
 
biostatistics.pptx research methodology
biostatistics.pptx  research methodologybiostatistics.pptx  research methodology
biostatistics.pptx research methodology
 
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptxMP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
 
absorption of drugs.ppt
absorption of drugs.pptabsorption of drugs.ppt
absorption of drugs.ppt
 
keerthy sir lesson 1.pptx
keerthy sir lesson 1.pptxkeerthy sir lesson 1.pptx
keerthy sir lesson 1.pptx
 
correlation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptxcorrelation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptx
 
Factors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptxFactors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptx
 

Último

Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 

Último (20)

Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
latest AZ-104 Exam Questions and Answers
latest AZ-104 Exam Questions and Answerslatest AZ-104 Exam Questions and Answers
latest AZ-104 Exam Questions and Answers
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 

Modern pharmaceutics

  • 1. URS-USER REQUIREMENT SPECIFICATIONS Presented by Girija G S M PHARM 1ST SEM DEPARTMENT OF PHARMACEUTICS MALLIGE COLLEGE OF PHARMACY 1
  • 2. 2 USER REQUIREMENT SPECIFICATIONS-URS → Requirements regarding equipment is given by users called as URS. It includes,  Size of equipment  Speed of equipment  Effectiveness of equipment  Availability of spares, change parts  Low dust and sound facilities  Auto control systems  Lesser breakdowns  Overall good construction
  • 3. 3  The requirement and specifications for the utility of equipment should be defined by the user and documented in the URS.  The URS should be used when selection of the required utility or equipment from an approved supplier and to verify suitability throughout the subsequent stages of qualification.  They must be comprehensive. Each and every requirement relating to product safety, identity, strength, purity, and quality must be identified.  The URS can contain a large number of requirements and should therefore be structured in a way that will permit easy access to information.  The requirement specification must be formally reviewed and approved by the pharmaceutical manufacturer.
  • 4. 4 The following guidelines should be followed during the production of the URS:  Each requirement statement to be uniquely referenced, and no longer than 250words.  Requirement statements should not be duplicated nor contradicted.  The URS should express requirements and not design solutions.  Each requirement should be testable.
  • 5. 5  The URS must be understood by both user and supplier; ambiguity avoided.  The use of diagrams is often useful  Wherever possible, the URS should distinguish between mandatory/regulatory requirements and desirable features.
  • 6. 6 U.R.S. for facilities is a statement spelling out, what the user wants in terms of the facilities, he wants to create for the manufacturing of the pharmaceutical formulations. It can expressed in the following manner. The facility will be used for the manufacture of the following formulation and volumes, namely: 1) Tablets-Coated 10L/Shift 2) Tablets-Uncoated 20L/Shift 3) Hard gelatin capsules 5L/Shift 4) Small volume parenterals 50K Amp/Shift 5) Large volume parenterals 20Kbottles of 500 ml/Shift
  • 7. 7 URS provides the following key benefits for the validation program: 1. Clarifies technical, quality, and documentation requirements to the vendor(s). 2. Enables the pharmaceutical manufacturer to assess the technical, regulatory, and commercial compliance (or otherwise) of submitted bids against a formal specification. 3. Ensures the basis of a structured approach to the presentation of information. 4. Provides a basis for testing and test acceptance criteria. 5. Provide a baseline for validation and verification..
  • 8. 8 Model Question 1) Write a note on USR?
  • 9. 9 References Pharmaceutical Process Validation, Second Edition, Revised and Expanded, edited by Ira R. Berry, Robert a. Nash. Validation in pharmaceutical industry; Equipment validation; A brief review, Diksha Jindal, et al; Adesh University Journal of Medical Sciences & Research. www.aujmsr.com
  • 10. 10